Blog

Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background

Accunea

Accunea is a medical device business that is developing novel point-of-care diagnostic and monitoring technologies for clinical centres.

 

Our premiere product is RenoSure, a bedside kidney function monitoring device that provides unprecedented capabilities for detecting Acute Kidney Injury (AKI) in hospital. Acute Kidney Injury affects 13-18% of all hospitalised patients worldwide, killing one fifth of those diagnosed. Managing this condition costs the UK in excess of £1bn/yr (1% of the total NHS budget), and still results in over 40,000 potentially avoidable deaths/yr.

www.accunea.com